Roberts W G, Palade G E
Cellular and Molecular Medicine, University of California-San Diego, La Jolla 92093-0651, USA.
Cancer Res. 1997 Feb 15;57(4):765-72.
We have reported previously that topical administration of vascular endothelial growth factor165 (VEGF) to a microvascular bed supplied with a continuous endothelium can rapidly induce the formation of endothelial fenestrations (W. G. Roberts and G. E. Palade, J. Cell Sci., 108: 2369-2379, 1995). From these results, we hypothesized that tumor vasculature, in general, may also be fenestrated because it has been reported that tumor secretion of VEGF causes the surrounding host vasculature to invade and feed the growing tumor. Using electron microscopy to characterize the endothelial cell morphology in tumor vessels from either the periphery or the core of the tumor and immunoblotting to detect secreted VEGF, we analyzed the vasculature of human and murine neoplastic tumors grown s.c. in male nude mice. To clarify the role of VEGF165 two models were used: (a) Chinese hamster ovary (CHO) cells stably transfected with hu VEGF165 and injected into mice (VEGF:CHO tumors); and (b) slow-release pellets containing purified VEGF or basic fibroblast growth factor implanted on the rat cremaster muscle. All tumors had vessels with fenestrated endothelium, open interendothelial junctions, and clustered fused caveolae. From all of the peripheral tumor vessels observed, fenestrated endothelium was observed in 41% from EMT, 35% from M1S, 37% from U87, and 56% from VEGF:CHO tumors, whereas surrounding skin and muscle, from which tumor vessels were derived, had fenestrated endothelium in 2 and 0% of all vessels, respectively. Additionally, further analysis revealed a substantial decrease in the anionic glycocalyx on the luminal face of the fenestral diaphragms in endothelium from tumors (especially VEGF:CHO) when compared to intestine or pancreas. Because the host tissue microvascular endothelium which supplies the tumor is not fenestrated, tumors can transform nonproliferating, nonfenestrated vessels into proliferating vessels, many of which have fenestrated endothelium. These data provide evidence that chronic VEGF exposure can induce fenestrations in nonfenestrated endothelium similar to the fenestrated endothelium found in tumor vessels.
我们之前报道过,向具有连续内皮的微血管床局部施用血管内皮生长因子165(VEGF)可迅速诱导内皮窗孔形成(W.G.罗伯茨和G.E.帕拉德,《细胞科学杂志》,108:2369 - 2379,1995)。基于这些结果,我们推测,一般而言肿瘤血管系统也可能是有窗孔的,因为有报道称肿瘤分泌的VEGF会导致周围宿主血管侵入并为生长中的肿瘤供血。我们利用电子显微镜来表征肿瘤外周或核心血管中内皮细胞的形态,并通过免疫印迹法检测分泌的VEGF,分析了在雄性裸鼠皮下生长的人源和鼠源肿瘤的血管系统。为阐明VEGF165的作用,使用了两种模型:(a)稳定转染人VEGF165并注射到小鼠体内的中国仓鼠卵巢(CHO)细胞(VEGF:CHO肿瘤);(b)将含有纯化VEGF或碱性成纤维细胞生长因子的缓释微丸植入大鼠提睾肌。所有肿瘤的血管都有内皮窗孔、开放的内皮间连接和聚集融合的小窝。在观察到的所有外周肿瘤血管中,EMT来源的血管有41%存在内皮窗孔,M1S来源的为35%,U87来源的为37%,VEGF:CHO肿瘤来源的为56%,而肿瘤血管所源自的周围皮肤和肌肉中,所有血管分别只有2%和0%存在内皮窗孔。此外,进一步分析显示,与肠或胰腺相比,肿瘤(尤其是VEGF:CHO)内皮窗孔隔膜腔面的阴离子糖萼显著减少。由于为肿瘤供血的宿主组织微血管内皮没有窗孔,肿瘤可将不增殖、无窗孔的血管转化为增殖性血管,其中许多血管具有内皮窗孔。这些数据证明,长期暴露于VEGF可诱导无窗孔内皮形成窗孔,类似于肿瘤血管中发现的有窗孔内皮。